Description

TAL/Tau Aggregation Inhibiting Peptide

TAL/Tau Aggregation Inhibiting Peptide for sale online at Peptides Link Labs. The function of Tau protein aggregation inhibitory peptides is to inhibit the aggregation of Tau protein. This may play a crucial role in the treatment of diseases related to Tau protein, such as Alzheimer’s disease.

Also, These peptides can pass through the blood-brain barrier and effectively inhibit the aggregation of Tau protein in both in vitro and in vivo models. And improve the associated neurodegenerative and behavioral defects.

T/T 10 10mg  Peptide Description

Inhibiting Tau protein aggregation: The core mechanism is to prevent the abnormal aggregation of Tau protein, which is one of the key factors leading to damage and death of nerve cells.

Improving neurodegenerative diseases: By inhibiting the aggregation of Tau protein. It helps to delay or improve the progression of neurodegenerative diseases, such as Alzheimer’s disease, etc.

Improving behavioral phenotypes: In disease models, these peptides not only can inhibit pathological changes but also can improve related behavioral problems.

Crossing the blood-brain barrier: Some of these peptides (such as RI-AG03) have oral activity and can cross the blood-brain barrier, which makes them potentially effective therapeutic drugs.

TAL/Tau Aggregation Inhibiting Peptide

Important Research Use Only Statement.
This T/T 10 10mg research peptide is supplied exclusively for in-vitro laboratory research and scientific investigation purposes. In conclusion, This product is not intended for human consumption, therapeutic use, or clinical application.

RUO disclaimer: For laboratory research use only. Not for human or veterinary consumption or therapeutic applications.